Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …

Background The gastrointestinal peptide hormone ghrelin was discovered in 1999 as the
endogenous ligand of the growth hormone secretagogue receptor. Increasing evidence …

People with obesity commonly face a pervasive, resilient form of social stigma. They are often
subject to discrimination in the workplace as well as in educational and healthcare settings…

Background The impact of COVID-19 on physical and mental health and employment after
hospitalisation with acute disease is not well understood. The aim of this study was to …

Background Obesity is a global health challenge with few pharmacologic options. Whether
adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 …

Food intake is regulated by the hypothalamus, including the melanocortin and neuropeptide
Y (NPY) systems in the arcuate nucleus 1 . The NPY Y2 receptor (Y2R), a putative inhibitory …

Background The gut hormone fragment peptide YY 3–36 (PYY) reduces appetite and food
intake when infused into subjects of normal weight. In common with the adipocyte hormone …

Ghrelin, a circulating growth hormone–releasing peptide derived from the stomach, stimulates
food intake. The lowest systemically effective orexigenic dose of ghrelin was investigated …

Background Health literacy has become an increasingly important concept in public health.
We sought to develop a comprehensive measure of health literacy capable of diagnosing …

Objective: To study the effect of bariatric surgery on the entero-hypothalamic endocrine axis
of humans and rodents. Background: Bariatric surgery is the most effective obesity treatment …